Allgens Medical Technology CO., LTD. (SHA:688613)

SHA:688613 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	208.18	200.43	218.43	240.28	234.15	183.76
Other Revenue	5.6	5.6	8.05	5.02	1.91	-
Revenue	213.78	206.03	226.48	245.31	236.06	183.76
Revenue Growth (YoY)	11.82%	-9.03%	-7.68%	3.91%	28.46%	9.00%
Cost of Revenue	70.06	59.4	39.24	40.79	35.62	29.96
Gross Profit	143.72	146.63	187.24	204.51	200.44	153.8
Selling, General & Admin	113.06	123.6	122.04	69.95	53.35	39.73
Research & Development	41.85	38.77	45.5	57.46	33.23	16.01
Other Operating Expenses	5.05	3.57	2.58	2.58	3.09	2.42
Operating Expenses	162.25	174.08	171.22	130.6	90.16	58.05
Operating Income	-18.52	-27.44	16.02	73.91	110.28	95.75
Interest Expense	-2.52	-2.95	-3.13	-1.87	-3.42	-1.28
Interest & Investment Income	1.5	15.06	6.18	5.62	4.28	0.13
Earnings From Equity Investments	-	-	-	-	0.53	2.03
Currency Exchange Gain (Loss)	-0.13	-0.13	0	0	-0	-0.38
Other Non Operating Income (Expenses)	-2.31	-1.13	-0.34	0.05	-0.07	-0.03
EBT Excluding Unusual Items	-21.99	-16.59	18.73	77.72	111.61	96.22
Gain (Loss) on Sale of Investments	13.68	6.35	15.1	10.2	14.39	2.5
Gain (Loss) on Sale of Assets	0.15	0.64	-0.59	-0.32	-	-0.08
Asset Writedown	-	-	-	-	-0.01	-
Other Unusual Items	3.54	0.66	15.85	8.61	6.07	3.43
Pretax Income	-4.62	-8.94	49.09	96.2	132.05	102.08
Income Tax Expense	1.11	8.2	-3.87	4.5	13.98	14.96
Earnings From Continuing Operations	-5.73	-17.14	52.97	91.7	118.07	87.12
Minority Interest in Earnings	2.12	4.48	1.27	3.52	2.71	1.83
Net Income	-3.61	-12.66	54.23	95.22	120.78	88.94
Net Income to Common	-3.61	-12.66	54.23	95.22	120.78	88.94
Net Income Growth	-	-	-43.04%	-21.17%	35.80%	31.22%
Shares Outstanding (Basic)	154	141	132	134	120	100
Shares Outstanding (Diluted)	154	141	132	134	120	100
Shares Change (YoY)	22.74%	6.36%	-1.37%	12.14%	19.66%	-0.06%
EPS (Basic)	-0.02	-0.09	0.41	0.71	1.01	0.89
EPS (Diluted)	-0.02	-0.09	0.41	0.71	1.01	0.89
EPS Growth	-	-	-42.25%	-29.70%	13.48%	31.30%
Free Cash Flow	-24.26	-33.03	29.78	56.63	68.54	28.47
Free Cash Flow Per Share	-0.16	-0.23	0.23	0.42	0.57	0.28
Dividend Per Share	-	-	0.060	0.107	0.272	-
Dividend Growth	-	-	-43.92%	-60.66%	-	-
Gross Margin	67.23%	71.17%	82.67%	83.37%	84.91%	83.70%
Operating Margin	-8.67%	-13.32%	7.07%	30.13%	46.72%	52.11%
Profit Margin	-1.69%	-6.15%	23.95%	38.82%	51.17%	48.40%
Free Cash Flow Margin	-11.35%	-16.03%	13.15%	23.09%	29.04%	15.50%
EBITDA	0.16	-10.43	30.81	88.11	121.03	107.06
EBITDA Margin	0.08%	-5.06%	13.61%	35.92%	51.27%	58.26%
D&A For EBITDA	18.69	17.02	14.79	14.2	10.75	11.31
EBIT	-18.52	-27.44	16.02	73.91	110.28	95.75
EBIT Margin	-8.67%	-13.32%	7.07%	30.13%	46.72%	52.11%
Effective Tax Rate	-	-	-	4.68%	10.59%	14.66%
Revenue as Reported	213.78	206.03	226.48	245.31	236.06	183.76

Source: S&P Global Market Intelligence. Standard template. Financial Sources.